alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
cme@

Chicago Mercantile Exchange

20 South Wacker Drive 312/930.1000 tef
Chicago, IL 60606-7499 312/466.4410 fax
www.cme.com

March 27, 2006

Ms. Jean A. Webb

Office of the Secretariat

Commodity Futures Trading Commission
Three Lafayette Centre

1155 21st Street, N.W.

Washington, DC 20581

Re: Section Sc(c)(1), Regulation 40.6(a) Submission. Self-Certification
of the Temporary Delisting and Rule Amendments for CME Butter Futures Contracts.
Submission #06-31

Dear Ms. Webb:

Chicago Mercantile Exchange, Inc. hereby informs the Commission of the temporary delisting of
the March and May 2007 Butter Futures and Options contracts in which there is no current open
interest. Re-listing of these contracts with the revised rule language will take place on Thursday,
March 30, 2006.

The temporary delisting is required to make necessary changes to the contract to remove
references to negotiable warehouse receipts that were recently removed during the revision
process to Chapter 7 of the CME Rulebook.

The amendments are as follows, with additions underlined and deletions bracketed and
overstruck.

5103.D. Seller's Duties

To make delivery, the seller shall furnish no later than 1:00 p.m. two business days prior to
delivery, to the Exchange's Clearing House, a written Delivery Notice on a form prescribed by
the Exchange. The buyer shall be notified by the Exchange no later than 3:00 p.m. of said day
unless such notification deadline is extended by the President. The seller shall present by 12:00


noon on the business day following the day of i intent, an Official Exchange Certificate, and a
USDA grading certificate indicating that the butter i is grade AA[,and-e-negotiable-warehouse

ti db: Exeh: ed ).
ip’ y a uSe.

5103.G. Completion of Delivery

Upon receipt of the buyer's payment and the seller's fulfillment of the delivery in accordance
with all the conditions of the contract herein set forth, the Clearing House shall release [the

|] the Official Exchange Certificate and USDA inspection
certificate to the buyer and make the corresponding payment to the seller.

5104.D. Deviations and Allowances

The delivery unit may vary between 40,000 and 43,000 pounds in net weight but payment shall
be made on the basis of the exact weight delivered [as-stated-enthe-warehouse-receipt].

The Exchange certifies that the temporary delisting and rule amendments for CME Butter
Futures Contracts comply with the Act & regulations thereunder.

If you require any additional information regarding this action, please do not hesitate to contact
Mr. Charles Piszczor at 312-930-4536 or via e-mail at cpiszczo@cme.com. We would be
appreciative if you could reference our CME Submission #06-31 in any related correspondence.

Sincerely,

John W. Labuszewski, Managing Director
Research & Product Development
OTIS JAMES WRIGHT,

Petitioner,

v.

STATE OF FLORIDA,

Respondent.

___________________________/

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D17-0265

Opinion filed February 1, 2017.

Petition for Writ of Habeas Corpus -- Original Jurisdiction.

Otis James Wright, pro se, Petitioner.

Pamela Jo Bondi, Attorney General, Tallahassee, for Respondent.

PER CURIAM.

DISMISSED. See Baker v. State, 878 So. 2d 1236 (Fla. 2004).

LEWIS, BILBREY, and WINOKUR, JJ., CONCUR.
Electronically Filed Intermediate Court of Appeals CAAP-15-0000802 26-JUL-2016 09:05 AM
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 1 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 2 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 3 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 4 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 5 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 6 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 7 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 8 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 9 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 10 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 11 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 12 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 13 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 14 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 15 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 16 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 17 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 18 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 19 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 20 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 21 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 22 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 23 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 24 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 25 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 26 of 27
Case 7:07-cv-05815-KMK-MDF Document 12-5 Filed 07/16/2007 Page 27 of 27
Exhibit 4.3





Exhibit 4.3




CERTIFICATE OF AMENDMENT

OF

RESTATED CERTIFICATE OF INCORPORATION

OF

LA JOLLA PHARMACEUTICAL COMPANY

a Delaware corporation




La Jolla Pharmaceutical Company, a corporation organized and existing under the laws of the
State of Delaware (the “Company”), hereby certifies as follows:



FIRST: That the Board of Directors of the Company has duly adopted resolutions (i) authorizing
the Company to execute and file with the Secretary of State of the State of Delaware this
Certificate of Amendment of Certificate of Incorporation (this “Certificate of Amendment”) to (a)
increase the number of authorized shares of Common Stock from 225,000,000 to 6,000,000,000; (b)
decrease the par value of the Company’s capital stock from $0.01 per share to $0.0001 per share;
and (c) change the authorized size of the Board of Directors, and (ii) declaring this Certificate
of Amendment to be advisable and recommended for approval by the stockholders of the Company.



SECOND: That this Certificate of Amendment was duly adopted in accordance with the provisions
of Section 242 of the General Corporation Law of the State of Delaware by the Board of Directors
and stockholders of the Company.



THIRD: That upon the effectiveness of this Certificate of Amendment, the first paragraph of
Article IV of the Restated Certificate of Incorporation of the Company is hereby deleted in its
entirety and replaced with the following:



“Article IV

Authorized Capital Stock





The Corporation is authorized to issue two classes of stock designated
“Common Stock” and “Preferred Stock.” The total number of shares of all
classes of stock that this Corporation is authorized to issue is Six Billion
Eight Million (6,008,000,000), consisting of Six Billion (6,000,000,000)
 shares of Common Stock, par value $0.0001 per share, and Eight Million
(8,000,000) shares of Preferred Stock, par value $0.0001 per share.”



FOURTH: That upon the effectiveness of this Certificate of Amendment, the first
two sentences of Article VIII of the Restated Certificate of Incorporation of the
Company are hereby deleted in their entirety and replaced with the following:




“The total number of directors of the Corporation shall be not less than
three (3) nor more than nine (9), with the actual total number of directors
set from time to time exclusively by resolution of the Board of
Directors. The Board of Directors shall initially consist of three members until
changed by such a resolution.”



 


 









 







IN WITNESS WHEREOF, the Company has caused this Certificate of Amendment of Restated
Certificate of Incorporation to be executed by Deirdre Y. Gillespie, its Chief Executive Officer,
this 16th day of August, 2010.



	 	 	 	 	 
	 	LA JOLLA PHARMACEUTICAL COMPANY

 	 
	 	By:  	/s/ Deirdre Gillespie
 	 
	 	 	Name:  	Deirdre Y. Gillespie 	 
	 	 	Title:  	Chief Executive Officer
Effective December 7, 2022

Attn: all DW SEF Participants 

DW SEF LLC (“DW SEF”) will be making changes in accordance with the revised Commodity Futures 

Trading Commission (CFTC) Swap Data Reporting (SDR) and public dissemination requirements. These 

changes will become effective starting December 5th 2022.

While these new changes mainly impact the Critical Data Elements (CDE) (as defined within the 

requirements) that DW SEF reports to the SDR, there will be minor changes to information captured 

regarding Participants (including CFTC Financial Entity Status, Federal Entity Indicator and SD/MSP 

Indicator). DW SEF will set the default value of the following fields as noted below:

Financial Entity Status- YES

Federal Entuty Indicator- NO

SD/MSP Indicator- This field will be populated by reviewing information previously provided by Participant 

regarding “SD” or “MSP.”

Additionally, pursuant to DW SEF Rule 303(a)(iv), Participants have an ongoing obligation to ensure the 

information provided to DW SEF is accurate. Should you have any questions about any of the values or 

information in the above noted fields, or any informartion that has previously been provided to DW SEF, 

please contact us at (201) 536-5780 or IRSsupport@dealerweb.com. Thank you.
Third District Court of Appeal

State of Florida 

Opinion filed November 15, 2023.

Not final until disposition of timely filed motion for rehearing.

________________

No. 3D22-205

Lower Tribunal No. 10-53384

________________

Doron Jockey Club, LLC, etc.,

Appellant,

vs.

B.V.K., LLC, etc.,

Appellee.

An Appeal from the Circuit Court for Miami-Dade County, William 

Thomas and Lisa S. Walsh, Judges.

Carlton Fields, P.A., and Dean A. Morande (West Palm Beach) and 

Christopher Smart (Tampa), for appellant.

Law Offices of Geoffrey B. Marks and Geoffrey B. Marks; Venable LLP 

and Jessie F. Beeber (New York, NY), for appellee.

Before LOGUE, C.J., and LINDSEY and LOBREE, JJ.

PER CURIAM.

Affirmed.
Order entered February 17, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00817-CR

No. 05-14-00818-CR

No. 05-14-00819-CR

WILLIAM RUSSELL DENVER, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 194th Judicial District Court

Dallas County, Texas

Trial Court Cause Nos. F12-62195-M, F12-62196-M, F14-00186-M

ORDER

The Court REINSTATES the appeals.

On January 14, 2015, we ordered the trial court to make findings regarding why the 

reporter’s record has not been filed in these appeals. We ADOPT the findings that: (1) 

appellant desires to pursue the appeals; (2) appellant is indigent and represented by courtappointed counsel; (3) counsel timely requested preparation of the record; (4) Belinda Baraka is 

the court reporter who recorded the proceedings; (5) Ms. Baraka explained the delay in filing the 

record was due to her “backlog of appellate records to prepare”; and (6) Ms. Baraka requested 

thirty days from the February 9, 2015 findings to file the reporter’s record.
We ORDER Belinda Baraka, official court reporter of the 194th Judicial District Court, 

to file the complete reporter’s record, including all exhibits admitted into evidence, by 4:00 p.m. 

on MARCH 13, 2015. We note the reporter’s record is already four months overdue. 

Therefore, no further extensions will be granted. If the reporter’s record is not filed by the date 

and time specified, the Court will order that Belinda Baraka not sit as a court reporter until the 

record is filed in these appeals.

We DIRECT the Clerk to send copies of this order, by electronic transmission, the 

Honorable Ernest White, Presiding Judge, 194th Judicial District Court; Belinda Baraka, official 

court reporter, 194th Judicial District Court; and to counsel for all parties.

/s/ ADA BROWN 

JUSTICE
# C_2005144EN.01000801.xml

| 14.6.2005 | EN | Official Journal of the European Union | C 144/8 |
| --- | --- | --- | --- |

14.6.2005

EN

Official Journal of the European Union

C 144/8

---

New Composition of the Experts Group on Trafficking in Human Beings

(2005/C 144/03)

(The Experts Group on Trafficking in Human Beings was set up by Commission Decision 2003/209/EC of 25 March 2003) (1)

(The Experts Group on Trafficking in Human Beings was set up by Commission Decision 2003/209/EC of 25 March 2003) (1

By Decision of 7 June 2005, the Commission has reappointed the following as members of the Experts Group on Trafficking in Human Beings from 1 March 2005 for a period of one year:

| | Mr. Jean-Michel Colombani |
| --- | --- |

Mr. Jean-Michel Colombani

| | Mr. Pippo Costella |
| --- | --- |

Mr. Pippo Costella

| | Ms. Mary Cunneen |
| --- | --- |

Ms. Mary Cunneen

| | Mr. Brice de Ruyver |
| --- | --- |

Mr. Brice de Ruyver

| | Mr. José Garcia Magariños |
| --- | --- |

Mr. José Garcia Magariños

| | Mr. Marco Gramegna |
| --- | --- |

Mr. Marco Gramegna

| | Mr. Krzysztof Karsznicki |
| --- | --- |

Mr. Krzysztof Karsznicki

| | Mr. Plamen Kolarski |
| --- | --- |

Mr. Plamen Kolarski

| | Ms. Martina Liebsch |
| --- | --- |

Ms. Martina Liebsch

| | Mr. Michel Marcus |
| --- | --- |

Mr. Michel Marcus

| | Ms. Isabella Orfano |
| --- | --- |

Ms. Isabella Orfano

| | Ms. Nell Rasmussen |
| --- | --- |

Ms. Nell Rasmussen

| | Ms. Elisabetta Rosi |
| --- | --- |

Ms. Elisabetta Rosi

| | Ms. Éva Rózsa |
| --- | --- |

Ms. Éva Rózsa

| | Mr. Henrik Sjölinder |
| --- | --- |

Mr. Henrik Sjölinder

| | Ms. Hana Snajdrova |
| --- | --- |

Ms. Hana Snajdrova

| | Ms. Gerda Theuermann |
| --- | --- |

Ms. Gerda Theuermann

| | Ms. Marina Tzvetkova |
| --- | --- |

Ms. Marina Tzvetkova

| | Ms. Bärbel Uhl |
| --- | --- |

Ms. Bärbel Uhl

| | Ms. Marjan Wijers |
| --- | --- |

Ms. Marjan Wijers

---

(1)  OJ L 79, 26.3.2003, p. 25.

1

---
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. Section 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





I, Ning C. Wu, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1)
the Quarterly Report on Form 10-Q of Medical Care Technologies Inc. for the quarter ended March 31, 2011 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Medical Care Technologies Inc.





Dated this 3rd day of May, 2011.





/s/ NING C. WUNing C. WuPresident, Principal Executive Officer

and a member of the Board of Directors




A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Medical Care Technologies Inc. and will be retained by Medical Care Technologies Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Quarterly Report on Form 10-Q of Momentive Performance Materials Inc. for the fiscal three-month
period ended September 27, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of Rule 13(a) and 15 (d) of the Securities Exchange Act of 1934;
| | -- | ----------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------



|                                         |  |  |  |                                              
|---------------------------------------- |  |  |  | ---------------------------------------------
|/s/ Jonathan D. Rich                     |  |  |  | /s/ Anthony S. Colatrella                    
|Jonathan D. Rich Chief
Executive Officer |  |  |  | Anthony S. Colatrella Chief
Financial Officer
|                                         |  | 
|DATE: November 10, 2009                  |  |  |  | DATE: November 10, 2009                      

A signed original of this written statement required by Section 906 has been
provided to Momentive Performance Materials Inc. and will be retained by Momentive Performance Materials Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Triplecrown Acquisition Corp. (the Company) on Form 10-Q for
the quarterly period ended March 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation of the Company.



|                   |  |                         |  |                              
|------------------ |  | ----------------------- |  | -----------------------------
|Date: May 15, 2008 |  | /s/ Jonathan J. Ledecky
|                   |  | Name:                   |  | Jonathan J. Ledecky          
|                   |  | Title:                  |  | President and Secretary      
|                   |  |                         |  | (Principal Executive Officer)



|                   |  |                    |  |                                             
|------------------ |  | ------------------ |  | --------------------------------------------
|Date: May 15, 2008 |  | /s/ Eric J. Watson
|                   |  | Name:              |  | Eric J. Watson                              
|                   |  | Title:             |  | Chairman of the Board and Treasurer         
|                   |  |                    |  | (Principal Accounting and Financial Officer)
# C_2019054EN.01003501.xml

| 11.2.2019 | EN | Official Journal of the European Union | C 54/35 |
| --- | --- | --- | --- |

11.2.2019

EN

Official Journal of the European Union

C 54/35

---

Order of the General Court of 7 December 2018 — Kaimbi v Council

(Case T-142/17) (1)

(2019/C 54/52)

Language of the case: French

The President of the Ninth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 129, 24.4.2017.

---
# C_2019423EN.01003301.xml

| 16.12.2019 | EN | Official Journal of the European Union | C 423/33 |
| --- | --- | --- | --- |

16.12.2019

EN

Official Journal of the European Union

C 423/33

---

Judgment of the General Court of 3 October 2019 – BASF v ECHA

(Case T-805/17) (1)

(REACH - Article 11 of Regulation (EC) No 1907/2006 - Article 3(3) of Implementing Regulation (EU) 2016/9 - Requirement for joint submission of data - Joint submission with possibility of a complete opt-out - Administrative practice of ECHA requiring an agreement on the terms for making a joint submission with the lead registrant for a registered substance - Failure to reach an agreement - Dispute resolution mechanism applied by analogy - Decision granting access to a joint submission - Legal basis - Broad discretion of ECHA - Manifest error of assessment - Obligation to state reasons - Legal certainty)

(2019/C 423/40)

Language of the case: English

Parties

Applicant: BASF SE (Ludwigshafen-am-Rhein, Germany) (represented by: R. Cana, D. Abrahams, E. Mullier and H. Widemann, lawyers)

Defendant: European Chemicals Agency (ECHA) (represented by: M. Heikkilä, C. Jacquet and T. Basmatzi, acting as Agents)

Re:

Action under Article 263 TFEU for the annulment of Decision DSH-30-3-0122-2017 of ECHA of 2 October 2017 granting Sustainability Support Services (Europe) AB access to the joint submission lodged by BASF, as lead registrant for the substance disodium 4,4'-bis[(4-anilino-6-morpholino-1, 3, 5-triazin-2-yl)amino]stilbene-2,2'-disulphonate, EC No 240-245-2 and CAS No 16090-02-1.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders BASF SE and the European Chemicals Agency (ECHA) to bear their own costs. |
| --- | --- |

2.

Orders BASF SE and the European Chemicals Agency (ECHA) to bear their own costs.

---

(1)  OJ C 52, 12.2.2018.

---
#### UNITED STATES of America, Plaintiff-Appellee, v. Darius BELLE, a/k/a Dee, Defendant-Appellant.

No. 12-8139.

United States Court of Appeals, Fourth Circuit.

Submitted: May 23, 2013.

Decided: May 28, 2013.

Darius Belle, Appellant Pro Se. Robert Frank Daley, Jr., Jimmie Ewing, Julius Ness Richardson, Jane Barrett Taylor, Assistant United States Attorneys, Columbia, South Carolina, for Appellee.

Before MOTZ and AGEE, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Dismissed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Darius Belle seeks to appeal the district court’s order denying relief on his 28 U.S.C.A. § 2255 (West Supp.2012) motion. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1)(B) *217(2006). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2006). When the district court denies relief on the merits, a prisoner satisfies this standard by demonstrating that reasonable jurists would find that the district court’s assessment of the constitutional claims is debatable or wrong. *Slack v. McDaniel,*529 U.S. 473, 484, 120 S.Ct. 1595, 146 L.Ed.2d 542 (2000); *see Miller-El v. Cockrell,*537 U.S. 322, 336-38, 123 S.Ct. 1029, 154 L.Ed.2d 931 (2003). When the district court denies relief on procedural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is debatable, and that the motion states a debatable claim of the denial of a constitutional right. *Slack,*529 U.S. at 484-85, 120 S.Ct. 1595.

We have independently reviewed the record and conclude that Belle has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

*DISMISSED.*